Its symptoms are sudden high blood pressure (over 140/90 mm Hg), protein in the urine, and laboratory abnormalities. Kidney and liver failure, stroke, and convulsions may occur in the mother, and complications due to stunted growth, oxygen deficiency, and premature birth may occur in the fetus.
With regard to preeclampsia, we distinguish between early (before 34 weeks) and late (after 34 weeks) forms. Clinically, early preeclampsia is of great importance.
With the help of a new method, early preeclampsia, which develops before the 34th week, can be detected as early as the 11th-13th week. week, the probability of the occurrence of toxemia can be screened and predicted. The purpose of the screening is to identify high-risk expectant mothers even before symptoms appear in the first trimester.
During the examination, we take into account the mother's age, body weight, general medical history, current blood pressure and the concentration of fetal proteins (PlGF, Papp-A). A special ultrasound examination is essential for risk assessment, with which we perform a Doppler examination of the arteries supplying the uterus. This screening test can screen out more than 90% of high-risk cases.
Prevention is possible in high-risk cases identified during screening. 14-36. with the effect of 150 mg of aspirin taken daily between weeks of pregnancy, early preeclampsia, i.e. before the 34th week, can be prevented in 80% or its onset can be postponed to a period when it no longer poses a risk of premature birth. The medicine is available without a prescription and can be used safely during pregnancy.
